Cinctive Capital Management Cuts Stake in Chemours

Hedge fund reduces position in specialty chemicals company by 77.6% in Q3

Mar. 17, 2026 at 8:09am

Got story updates? Submit your updates here. ›

Cinctive Capital Management LP decreased its stake in shares of The Chemours Company (NYSE:CC) by 77.6% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 74,457 shares of the specialty chemicals company's stock after selling 258,396 shares during the quarter.

Why it matters

This filing provides insight into the investment strategy and portfolio changes of Cinctive Capital Management, a hedge fund that focuses on the specialty chemicals industry. The significant reduction in Chemours holdings suggests the fund may have a bearish outlook on the company or the broader sector.

The details

Cinctive Capital Management's 13F filing shows the fund sold 258,396 shares of Chemours in Q3, reducing its total position to 74,457 shares worth $1,179,000. This represents a 77.6% decrease in the fund's Chemours holdings compared to the prior quarter. The filing does not provide details on the rationale behind the portfolio changes.

  • Cinctive Capital Management filed its 13F report for Q3 2026 on March 17, 2026.

The players

Cinctive Capital Management LP

A hedge fund that focuses on investments in the specialty chemicals industry.

The Chemours Company

A global chemistry company that produces performance chemicals, including fluoroproducts, titanium technologies, and chemical solutions.

Got photos? Submit your photos here. ›

The takeaway

This filing highlights the shifting investment strategies of hedge funds in the specialty chemicals sector, as Cinctive Capital Management significantly reduced its position in Chemours. Investors will likely watch for further portfolio changes and commentary from the fund to gauge its outlook on the company and the broader industry.